PRIVIA HEALTH GROUP INC (PRVA) Stock Fundamental Analysis

NASDAQ:PRVA • US74276R1023

23.75 USD
-1.16 (-4.66%)
At close: Feb 27, 2026
23.75 USD
0 (0%)
After Hours: 2/27/2026, 8:27:42 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to PRVA. PRVA was compared to 101 industry peers in the Health Care Providers & Services industry. While PRVA has a great health rating, there are worries on its profitability. PRVA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year PRVA was profitable.
  • In the past year PRVA had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: PRVA reported negative net income in multiple years.
  • Of the past 5 years PRVA 4 years had a positive operating cash flow.
PRVA Yearly Net Income VS EBIT VS OCF VS FCFPRVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

  • PRVA has a Return On Assets (1.34%) which is in line with its industry peers.
  • The Return On Equity of PRVA (2.56%) is comparable to the rest of the industry.
  • The Return On Invested Capital of PRVA (2.45%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 1.34%
ROE 2.56%
ROIC 2.45%
ROA(3y)0.83%
ROA(5y)-3.09%
ROE(3y)1.55%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
PRVA Yearly ROA, ROE, ROICPRVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

  • With a Profit Margin value of 0.89%, PRVA perfoms like the industry average, outperforming 53.47% of the companies in the same industry.
  • PRVA's Profit Margin has declined in the last couple of years.
  • PRVA has a Operating Margin of 1.38%. This is comparable to the rest of the industry: PRVA outperforms 43.56% of its industry peers.
  • PRVA's Operating Margin has declined in the last couple of years.
  • PRVA has a worse Gross Margin (10.17%) than 74.26% of its industry peers.
  • PRVA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.38%
PM (TTM) 0.89%
GM 10.17%
OM growth 3YN/A
OM growth 5Y-13.74%
PM growth 3YN/A
PM growth 5Y-4.5%
GM growth 3Y15.6%
GM growth 5Y3.18%
PRVA Yearly Profit, Operating, Gross MarginsPRVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • PRVA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • There is no outstanding debt for PRVA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PRVA Yearly Shares OutstandingPRVA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
PRVA Yearly Total Debt VS Total AssetsPRVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • PRVA has an Altman-Z score of 4.62. This indicates that PRVA is financially healthy and has little risk of bankruptcy at the moment.
  • PRVA's Altman-Z score of 4.62 is amongst the best of the industry. PRVA outperforms 80.20% of its industry peers.
  • PRVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.62
ROIC/WACC0.28
WACC8.61%
PRVA Yearly LT Debt VS Equity VS FCFPRVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 1.67 indicates that PRVA should not have too much problems paying its short term obligations.
  • PRVA's Current ratio of 1.67 is fine compared to the rest of the industry. PRVA outperforms 66.34% of its industry peers.
  • A Quick Ratio of 1.67 indicates that PRVA should not have too much problems paying its short term obligations.
  • The Quick ratio of PRVA (1.67) is better than 71.29% of its industry peers.
Industry RankSector Rank
Current Ratio 1.67
Quick Ratio 1.67
PRVA Yearly Current Assets VS Current LiabilitesPRVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • PRVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.55%, which is quite impressive.
  • The Earnings Per Share has been growing by 9.35% on average over the past years. This is quite good.
EPS 1Y (TTM)54.55%
EPS 3Y9.35%
EPS 5YN/A
EPS Q2Q%133.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-31.71%

3.2 Future

  • PRVA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 62.69% yearly.
  • The Revenue is expected to grow by 12.09% on average over the next years. This is quite good.
EPS Next Y89.34%
EPS Next 2Y62.69%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.51%
Revenue Next 2Y11.2%
Revenue Next 3Y12.31%
Revenue Next 5Y12.09%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PRVA Yearly Revenue VS EstimatesPRVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B
PRVA Yearly EPS VS EstimatesPRVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 139.71, PRVA can be considered very expensive at the moment.
  • PRVA's Price/Earnings is on the same level as the industry average.
  • PRVA is valuated expensively when we compare the Price/Earnings ratio to 27.10, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 73.78, the valuation of PRVA can be described as expensive.
  • The rest of the industry has a similar Price/Forward Earnings ratio as PRVA.
  • The average S&P500 Price/Forward Earnings ratio is at 28.06. PRVA is valued rather expensively when compared to this.
Industry RankSector Rank
PE 139.71
Fwd PE 73.78
PRVA Price Earnings VS Forward Price EarningsPRVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • 65.35% of the companies in the same industry are cheaper than PRVA, based on the Enterprise Value to EBITDA ratio.
  • PRVA's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 26.39
EV/EBITDA 70.33
PRVA Per share dataPRVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • PRVA's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • PRVA's earnings are expected to grow with 62.69% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.56
PEG (5Y)N/A
EPS Next 2Y62.69%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for PRVA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PRIVIA HEALTH GROUP INC

NASDAQ:PRVA (2/27/2026, 8:27:42 PM)

After market: 23.75 0 (0%)

23.75

-1.16 (-4.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-26
Earnings (Next)05-06
Inst Owners98.68%
Inst Owner Change0.49%
Ins Owners1.85%
Ins Owner Change0%
Market Cap2.92B
Revenue(TTM)N/A
Net Income(TTM)18.17M
Analysts84.29
Price Target32.15 (35.37%)
Short Float %2.31%
Short Ratio3.8
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-34.97%
Min EPS beat(2)-60.96%
Max EPS beat(2)-8.97%
EPS beat(4)0
Avg EPS beat(4)-37.14%
Min EPS beat(4)-60.96%
Max EPS beat(4)-8.97%
EPS beat(8)0
Avg EPS beat(8)-42.01%
EPS beat(12)3
Avg EPS beat(12)40.52%
EPS beat(16)6
Avg EPS beat(16)56.54%
Revenue beat(2)2
Avg Revenue beat(2)11.82%
Min Revenue beat(2)5.73%
Max Revenue beat(2)17.91%
Revenue beat(4)4
Avg Revenue beat(4)8.08%
Min Revenue beat(4)0.75%
Max Revenue beat(4)17.91%
Revenue beat(8)8
Avg Revenue beat(8)5.39%
Revenue beat(12)10
Avg Revenue beat(12)0.33%
Revenue beat(16)10
Avg Revenue beat(16)-9.08%
PT rev (1m)-0.08%
PT rev (3m)-0.1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-39.01%
EPS NY rev (1m)0%
EPS NY rev (3m)-20.77%
Revenue NQ rev (1m)-7.75%
Revenue NQ rev (3m)-29.23%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-37.44%
Valuation
Industry RankSector Rank
PE 139.71
Fwd PE 73.78
P/S 1.43
P/FCF 26.39
P/OCF 26.39
P/B 4.12
P/tB 7.91
EV/EBITDA 70.33
EPS(TTM)0.17
EY0.72%
EPS(NY)0.32
Fwd EY1.36%
FCF(TTM)0.9
FCFY3.79%
OCF(TTM)0.9
OCFY3.79%
SpS16.61
BVpS5.77
TBVpS3
PEG (NY)1.56
PEG (5Y)N/A
Graham Number4.7
Profitability
Industry RankSector Rank
ROA 1.34%
ROE 2.56%
ROCE 3.67%
ROIC 2.45%
ROICexc 5.77%
ROICexgc N/A
OM 1.38%
PM (TTM) 0.89%
GM 10.17%
FCFM 5.42%
ROA(3y)0.83%
ROA(5y)-3.09%
ROE(3y)1.55%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5Y-10.22%
OM growth 3YN/A
OM growth 5Y-13.74%
PM growth 3YN/A
PM growth 5Y-4.5%
GM growth 3Y15.6%
GM growth 5Y3.18%
F-Score7
Asset Turnover1.51
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 112.37
Cash Conversion 296.89%
Profit Quality 609.36%
Current Ratio 1.67
Quick Ratio 1.67
Altman-Z 4.62
F-Score7
WACC8.61%
ROIC/WACC0.28
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.55%
EPS 3Y9.35%
EPS 5YN/A
EPS Q2Q%133.33%
EPS Next Y89.34%
EPS Next 2Y62.69%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-31.71%
Revenue Next Year13.51%
Revenue Next 2Y11.2%
Revenue Next 3Y12.31%
Revenue Next 5Y12.09%
EBIT growth 1Y114.42%
EBIT growth 3YN/A
EBIT growth 5Y1.07%
EBIT Next Year573.42%
EBIT Next 3Y110.95%
EBIT Next 5Y64.24%
FCF growth 1Y142.02%
FCF growth 3Y26.09%
FCF growth 5Y42.42%
OCF growth 1Y141.5%
OCF growth 3Y25.67%
OCF growth 5Y35.01%

PRIVIA HEALTH GROUP INC / PRVA FAQ

What is the fundamental rating for PRVA stock?

ChartMill assigns a fundamental rating of 4 / 10 to PRVA.


Can you provide the valuation status for PRIVIA HEALTH GROUP INC?

ChartMill assigns a valuation rating of 2 / 10 to PRIVIA HEALTH GROUP INC (PRVA). This can be considered as Overvalued.


Can you provide the profitability details for PRIVIA HEALTH GROUP INC?

PRIVIA HEALTH GROUP INC (PRVA) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for PRVA stock?

The Price/Earnings (PE) ratio for PRIVIA HEALTH GROUP INC (PRVA) is 139.71 and the Price/Book (PB) ratio is 4.12.


Can you provide the financial health for PRVA stock?

The financial health rating of PRIVIA HEALTH GROUP INC (PRVA) is 7 / 10.